Építés alatt – nem éles oldal
Belépés

NCT06848192Visszavonva

The Parkinson's Disease Case-Control Study

The Parkinson's Disease Case-Control Study: Gut Microbiome Study for Parkinson's Disease

Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. szept. 29.

Megadott ok: Due to challenges in obtaining faecal samples from patients with Parkinson's disease, a population frequently affected by constipation.

Rövid összefoglaló (regiszter, angolul)

The Parkinson's Disease Case-Control Study is a study of healthy volunteers and patients with Parkinson's disease aged 50-75 years living in Hangzhou, China. This study aims to systematically investigate the differences in intestinal fungi between patients and healthy volunteers, find the key strains, and explore the molecular mechanism of Parkinson's disease with multi-omics data. Another aim of this study is to explore the association between intestinal fungi and brain structure and function from the perspective of the gut-brain axis by combining brain image data.

Állapot (regiszter)
Visszavonva
Vizsgálattípus
Megfigyeléses
Résztvevők száma
0 (tényleges)
Első benyújtás
2025. febr. 19.
Kezdés
2025. márc. 5.
Elsődleges befejezés
2025. dec. 1.
Fő szponzor
Westlake University
Betegségek
Parkinson-kór
NCT-szám
NCT06848192

Ki nem vehet részt

Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

Korábbi kezelés

  • Previous MRI scans showed clinically significant neurological disorders (as judged by the investigator).
  • Antibiotics have been used within 3 months prior to sample collection.
  • Previous MRI scans showed clinically significant neurological disorders (as judged by the investigator).
  • Use of the following drugs in the 6 months prior to the screening visit: dopamine blockers (antipsychotics), metoclopramide, and riserpine.
  • Antibiotics have been used within 3 months prior to sample collection.

Más betegség

  • Atypical or secondary parkinsonism due to medications (e.g., metoclopramide, flunarizine, antipsychotics) or metabolic diseases (e.g., Wilson's disease), encephalitis, or degenerative diseases (e.g., progressive supranuclear palsy).
  • The presence of clinically diagnosed dementia as determined by the investigator.
  • Serious illness (e.g., heart failure or malignancy).
  • Smoking more than 15 cigarettes a day and a history of alcohol or drug addiction
  • Inflammatory gastrointestinal diseases.
  • Chronic diseases that may affect the gut microorganism (e.g., diabetes, cirrhosis, or cardiovascular disease).
  • Blood or autoimmune disease, or use of immunosuppressants in the past 3 months.
  • Have a first-degree relative with Parkinson's disease (e.g. biological parent, sibling, or child).
  • Current or past clinically significant neurological disorders (as judged by the investigator).
  • Inflammatory gastrointestinal diseases.
  • Smoking more than 15 cigarettes a day and a history of alcohol or drug addiction
  • Chronic diseases that may affect the gut microorganism (e.g., diabetes, cirrhosis, or cardiovascular disease).
  • Blood or autoimmune disease, or use of immunosuppressants in the past 3 months.

Egyéb

  • (For PD patients)
  • Chronic constipation.
    • (For healthy volunteers)
  • Chronic constipation.
  • Participating in other clinical trials

Kiket keres a vizsgálat

  • (For PD patients)
  • Men or women aged 50 to 75 years.
  • Clinical diagnosis of Parkinson's disease (based on MDS Parkinson's disease diagnostic criteria)
  • The patient must have at least two of the following symptoms: static tremor, bradykinesia, stiffness (which must include at least static tremor or bradykinesia); Or have asymmetrical resting tremors or asymmetrical bradykinesia.
  • Able to provide informed consent.
    • (For healthy volunteers)
  • Age (±2 years) and sex-matched healthy control individuals for each Parkinson's disease patient.
  • Able to provide informed consent.

Életkor a regiszterben: 50 év – 75 év · Nem: nők és férfiak · Egészséges önkénteseket is fogad

A teljes feltétellista: ClinicalTrials.gov

Helyszínek (1)

Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.

HelyszínVárosOrszágHelyszín állapota
The First Affiliated Hospital Zhejiang University School of MedicineHangzhouKínaIsmeretlen állapot

Te vagy a koordinátor? Erősítsd meg az adatokat

Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.